Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
08/28/1996 | EP0728199A1 Dna virus ribozymes |
08/28/1996 | EP0728198A1 Isolation of nucleic acid |
08/28/1996 | EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM |
08/28/1996 | EP0728192A1 Recombinant yeasts for effective fermentation of glucose and xylose |
08/28/1996 | EP0728191A1 A secretion sequence for the production of a heterologous protein in yeast |
08/28/1996 | EP0728147A1 Receptor specific atrial natriuretic peptides |
08/28/1996 | EP0728146A1 Conotoxin peptides |
08/28/1996 | EP0728143A1 Oncoprotein protein kinase |
08/28/1996 | EP0728142A1 Novel antler-derived bone growth factors |
08/28/1996 | EP0728141A1 A method for identifying anti-parasitic compounds |
08/28/1996 | EP0728139A1 Amine-derivatized nucleosides and oligonucleosides |
08/28/1996 | EP0728018A1 Therapy |
08/28/1996 | EP0728015A1 Combinatorial polypeptide antigens |
08/28/1996 | EP0728014A1 Vaccines expressed in plants |
08/28/1996 | EP0728011A1 Growth factor compositions, preparation and use |
08/28/1996 | EP0571407B1 Cloning of a new member of the fibroblast growth factor (fgf) receptor family |
08/28/1996 | EP0533942B1 Process for expressing polypeptide |
08/28/1996 | EP0444115B1 In situ suppression hybridization and uses therefor |
08/28/1996 | EP0406297B1 Medical use of neuropeptide Antagonist G |
08/28/1996 | EP0313578B1 Novel osteoinductive compositions |
08/28/1996 | CN1129958A Method of identifying human and animal cells capable of unlimited proliferation or tumour formation |
08/28/1996 | CN1129955A A truncated keratinocyte growth factor (KGF) having increased biological activity |
08/28/1996 | CN1129953A Synthesis of saccharic composition |
08/28/1996 | CN1129944A Novel protein and process for producing the same |
08/28/1996 | CN1129738A High performance gene carrying system of virus liposomes |
08/28/1996 | CN1129737A Modified protein for gene transfer and process for producing the same |
08/27/1996 | US5550318 Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
08/27/1996 | US5550316 Transgenic animal model system for human cutaneous melanoma |
08/27/1996 | US5550289 N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor |
08/27/1996 | US5550228 Vectors; transformed microorganisms and protoplasts; plant cells |
08/27/1996 | US5550223 Lipoprotein I (ompi) of pseudomonas aeruginosa |
08/27/1996 | US5550221 Genetic engineering |
08/27/1996 | US5550214 Isolated antigenic oncogene peptide fragments and uses |
08/27/1996 | US5550109 Having antimicrobial, antifungal activity |
08/27/1996 | US5550060 Method and procedure for preparing red blood fractions |
08/27/1996 | US5550052 Useful for detection of lav antibodies in human sera |
08/27/1996 | US5550049 Useful as insecticides and arachnicidic agents |
08/27/1996 | US5550047 Genetic engineering |
08/27/1996 | US5550046 For production of starches |
08/27/1996 | US5550045 Efficient production of enzyme useful for degrading pectin |
08/27/1996 | US5550043 Expression of heterologous proteins in Drosophila cells |
08/27/1996 | US5550042 Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same |
08/27/1996 | US5550041 Caffeine demethylate gene-containing DNA fragment and microbial process for producing 3-methyl-7-alkylxanthine |
08/27/1996 | US5550040 Method, reagents and kits for the detection of Neisseria gonorrhoeae |
08/27/1996 | US5550038 Molecular farming |
08/27/1996 | US5550037 Dna clones |
08/27/1996 | US5550036 Method for co-amplification of human protein C genes in human cells |
08/27/1996 | US5550035 Dna based cytoplsamic viruses such as poxvirus and iridovirus; bacteriophase rna polymerase |
08/27/1996 | US5550025 Detection of hydrophobic amplification products by extraction into an organic phase |
08/27/1996 | US5550023 Amplification of human MDM2 gene in human tumors |
08/27/1996 | US5550019 Methods of identifying compounds which alter apoptosis |
08/27/1996 | US5550018 Testing for presence of uridine to cytidine substitution at nucleotide position 472, comparing percentage of revertant viruses in unclassified vaccine to that in accepted reference attenuated by cytidine to uridine substitution |
08/27/1996 | US5550016 Oligonucleotides of HCV, primers and probes therefrom, method of determining HCV genotypes and method of detecting HCV in samples |
08/27/1996 | US5549897 High molecular weight surface proteins of non-typeable haemophilus |
08/27/1996 | US5549892 Enhanced in vivo uptake of glucocerebrosidase |
08/27/1996 | US5549674 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
08/27/1996 | CA1338557C Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences |
08/23/1996 | CA2143150A1 Process for structurally analyzing the genome of viral and subviral pathogens |
08/22/1996 | WO1996025666A1 NF-λB ACTIVATION REGULATORY PROTEIN, IλB-BETA |
08/22/1996 | WO1996025520A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth |
08/22/1996 | WO1996025519A1 Virulence-attenuating genetic deletions |
08/22/1996 | WO1996025518A1 Probe for use in nucleic acid analysis and detecting method |
08/22/1996 | WO1996025515A1 A rapid test for determining the amount of functionally inactive gene in a gene therapy vector preparation |
08/22/1996 | WO1996025512A1 Microorganism of genus chrysosporium for use in preparing farnesyl transferase inhibitors |
08/22/1996 | WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
08/22/1996 | WO1996025508A1 Nucleic acid-containing composition, preparation and use thereof |
08/22/1996 | WO1996025507A2 Methods of preparation and use of recombinant adenoviral vectors |
08/22/1996 | WO1996025506A1 Method for preparing a recombinant adenovirus genome |
08/22/1996 | WO1996025505A1 Methods for maintaining sterility in plants |
08/22/1996 | WO1996025504A1 Genetic modification of plants |
08/22/1996 | WO1996025503A1 Plasmid-derived type ii restriction-modification systems from lactococcus lactis |
08/22/1996 | WO1996025502A1 Calcineurin regulatable adenylate cyclase |
08/22/1996 | WO1996025501A2 Method and composition for regulating apoptosis |
08/22/1996 | WO1996025500A1 Genes coding for proteins having acyl transfer activity |
08/22/1996 | WO1996025499A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer |
08/22/1996 | WO1996025498A2 Mpl ligand analogs |
08/22/1996 | WO1996025497A1 New chemokines expressed in pancreas |
08/22/1996 | WO1996025496A1 PRODUCTION OF BIOLOGICALLY ACTIVE RECOMBINANT BOVINE FOLLICLE STIMULATING HORMONE (REC bFSH) IN THE BACULOVIRUS EXPRESSION SYSTEM |
08/22/1996 | WO1996025495A1 Sperm factor |
08/22/1996 | WO1996025494A1 Transcription factor - e2f-5 |
08/22/1996 | WO1996025493A1 Multiple-tumor aberrant growth genes |
08/22/1996 | WO1996025492A1 EUKARYOTIC INITIATION FACTOR 5A (eIF-5A) MUTANTS |
08/22/1996 | WO1996025491A2 Inhibition of proliferation of vascular smooth muscle cell |
08/22/1996 | WO1996025488A1 A constitutively active phosphatidylinositol 3-kinase and uses thereof |
08/22/1996 | WO1996025487A1 Materials and methods relating to the regulation of polypeptide production in cells |
08/22/1996 | WO1996025435A1 MONOCLONAL ANTIBODY SPECIFIC FOR βA4 PEPTIDE |
08/22/1996 | WO1996025434A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
08/22/1996 | WO1996025432A1 Human g-protein coupled receptor |
08/22/1996 | WO1996025429A1 Insecticidal toxins from bracon hebetor |
08/22/1996 | WO1996025424A1 Bacterial catabolism of chitin |
08/22/1996 | WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
08/22/1996 | WO1996025422A1 Keratinocyte growth factor-2 |
08/22/1996 | WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY |
08/22/1996 | WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression |
08/22/1996 | WO1996025041A1 Insecticidal peptides from spider venom |
08/22/1996 | WO1996019498A3 T cell stimulating protein of pestivirus |
08/22/1996 | WO1996018722A3 Process for obtaining improved strains of trichoderma spp. |
08/22/1996 | WO1996017941A3 Production of c-terminal amidated peptides from recombinant protein constructs |
08/22/1996 | WO1996017935A3 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
08/22/1996 | WO1996015149A3 Methods and compositions for screening for presynaptic calcium channel blockers |